-
Something wrong with this record ?
Cross-Cultural Adaptation and Clinical Validation of TIME Criteria to Detect Potentially Inappropriate Medication Use in Older Adults: Methodological Report from the TIME International Study Group
G. Bahat, T. Erdogan, B. Can, S. Ozkok, B. Ilhan, A. Tufan, MA. Karan, A. Benetos, A. Cherubini, M. Drey, D. Garfinkel, J. Gąsowski, A. Renom-Guiteras, M. Kotsani, L. McCarthy, G. Onder, F. Pazan, K. Piotrowicz, P. Rochon, G. Ruppe, W. Thompson,...
Language English Country New Zealand
Document type Journal Article
- MeSH
- Humans MeSH
- Inappropriate Prescribing statistics & numerical data prevention & control MeSH
- Aged MeSH
- Potentially Inappropriate Medication List * MeSH
- Cross-Cultural Comparison MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Various explicit screening tools, developed mostly in central Europe and the USA, assist clinicians in optimizing medication use for older adults. The Turkish Inappropriate Medication use in oldEr adults (TIME) criteria set, primarily based on the STOPP/START criteria set, is a current explicit tool originally developed for Eastern Europe and subsequently validated for broader use in Central European settings. Reviewed every three months to align with the latest scientific literature, it is one of the most up-to-date tools available. The tool is accessible via a free mobile app and website platforms, ensuring convenience for clinicians and timely integration of updates as needed. Healthcare providers often prefer to use their native language in medical practice, highlighting the need for prescribing tools to be translated and adapted into multiple languages to promote optimal medication practices. OBJECTIVE: To describe the protocol for cross-cultural and language validation of the TIME criteria in various commonly used languages and to outline its protocol for clinical validation across different healthcare settings. METHODS: The TIME International Study Group comprised 24 geriatric pharmacotherapy experts from 12 countries. In selecting the framework for the study, we reviewed the steps and outcomes from previous research on cross-cultural adaptations and clinical validations of explicit tools. Assessment tools were selected based on both their validity in accurately addressing the relevant issues and their feasibility for practical implementation. The drafted methodology paper was circulated among the study group members for feedback and revisions leading to a final consensus. RESULTS: The research methodology consists of two phases. Cross-cultural adaptation/language validation phase follows the 8-step approach recommended by World Health Organization. This phase allows regions or countries to make modifications to existing criteria or introduce new adjustments based on local prescribing practices and available medications, as long as these adjustments are supported by current scientific evidence. The second phase involves the clinical validation, where participants will be randomized into two groups. The control group will receive standard care, while the intervention group will have their treatment evaluated by clinicians who will review the TIME criteria and consider its recommendations. A variety of patient outcomes (i.e., number of hospital admissions, quality of life, number of regular medications [including over the counter medications], geriatric syndromes and mortality) in different healthcare settings will be investigated. CONCLUSION: The outputs of this methodological report are expected to promote broader adoption of the TIME criteria. Studies building on this work are anticipated to enhance the identification and management of inappropriate medication use and contribute to improved patient outcomes.
Amsterdam Public Health Aging and Later Life Amsterdam The Netherlands
Center for Appropriate Medication Use Sheba Medical Center Tel Hashomer Ramat Gan Israel
Department of Clinical and Molecular Sciences Universita Politecnica delle Marche Ancona Italy
Department of Geriatric Medicine Hospital del Mar Barcelona Spain
Department of Medicine 4 LMU University Hospital LMU Munich Munich Germany
Division of Geriatrics Department of Internal Medicine Liv Hospital Istanbul Turkey
European Geriatric Medicine Society Vienna Austria
Faculty of Health and Social Sciences South Bohemian University Ceske Budejovice Czech Republic
Fondazione Policlinico Gemelli IRCCS and Università Cattolica del Sacro Cuore Rome Italy
Geriatria Accettazione Geriatrica e Centro di Ricerca Per l'invecchiamento IRCCS INRCA Ancona Italy
Leslie Dan Faculty of Pharmacy University of Toronto Toronto Canada
Women's Age Lab and Women's College Research Institute Women's College Hospital Toronto ON Canada
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25010438
- 003
- CZ-PrNML
- 005
- 20250429134551.0
- 007
- ta
- 008
- 250415s2025 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s40266-024-01164-3 $2 doi
- 035 __
- $a (PubMed)39688727
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Bahat, Gulistan $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Çapa, 34093, Istanbul, Turkey. gbahatozturk@yahoo.com $1 https://orcid.org/0000000160395866
- 245 10
- $a Cross-Cultural Adaptation and Clinical Validation of TIME Criteria to Detect Potentially Inappropriate Medication Use in Older Adults: Methodological Report from the TIME International Study Group / $c G. Bahat, T. Erdogan, B. Can, S. Ozkok, B. Ilhan, A. Tufan, MA. Karan, A. Benetos, A. Cherubini, M. Drey, D. Garfinkel, J. Gąsowski, A. Renom-Guiteras, M. Kotsani, L. McCarthy, G. Onder, F. Pazan, K. Piotrowicz, P. Rochon, G. Ruppe, W. Thompson, E. Topinkova, N. van der Velde, M. Petrovic
- 520 9_
- $a BACKGROUND: Various explicit screening tools, developed mostly in central Europe and the USA, assist clinicians in optimizing medication use for older adults. The Turkish Inappropriate Medication use in oldEr adults (TIME) criteria set, primarily based on the STOPP/START criteria set, is a current explicit tool originally developed for Eastern Europe and subsequently validated for broader use in Central European settings. Reviewed every three months to align with the latest scientific literature, it is one of the most up-to-date tools available. The tool is accessible via a free mobile app and website platforms, ensuring convenience for clinicians and timely integration of updates as needed. Healthcare providers often prefer to use their native language in medical practice, highlighting the need for prescribing tools to be translated and adapted into multiple languages to promote optimal medication practices. OBJECTIVE: To describe the protocol for cross-cultural and language validation of the TIME criteria in various commonly used languages and to outline its protocol for clinical validation across different healthcare settings. METHODS: The TIME International Study Group comprised 24 geriatric pharmacotherapy experts from 12 countries. In selecting the framework for the study, we reviewed the steps and outcomes from previous research on cross-cultural adaptations and clinical validations of explicit tools. Assessment tools were selected based on both their validity in accurately addressing the relevant issues and their feasibility for practical implementation. The drafted methodology paper was circulated among the study group members for feedback and revisions leading to a final consensus. RESULTS: The research methodology consists of two phases. Cross-cultural adaptation/language validation phase follows the 8-step approach recommended by World Health Organization. This phase allows regions or countries to make modifications to existing criteria or introduce new adjustments based on local prescribing practices and available medications, as long as these adjustments are supported by current scientific evidence. The second phase involves the clinical validation, where participants will be randomized into two groups. The control group will receive standard care, while the intervention group will have their treatment evaluated by clinicians who will review the TIME criteria and consider its recommendations. A variety of patient outcomes (i.e., number of hospital admissions, quality of life, number of regular medications [including over the counter medications], geriatric syndromes and mortality) in different healthcare settings will be investigated. CONCLUSION: The outputs of this methodological report are expected to promote broader adoption of the TIME criteria. Studies building on this work are anticipated to enhance the identification and management of inappropriate medication use and contribute to improved patient outcomes.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a seznam potenciálně nevhodných léčiv $7 D000067561
- 650 _2
- $a srovnání kultur $7 D003431
- 650 _2
- $a nevhodné předepisování $x statistika a číselné údaje $x prevence a kontrola $7 D057970
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Erdogan, Tugba $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Çapa, 34093, Istanbul, Turkey
- 700 1_
- $a Can, Busra $u Division of Geriatrics, Department of Internal Medicine, Marmara University Medical School, Pendik, Istanbul, Turkey
- 700 1_
- $a Ozkok, Serdar $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Çapa, 34093, Istanbul, Turkey
- 700 1_
- $a Ilhan, Birkan $u Division of Geriatrics, Department of Internal Medicine, Liv Hospital, Istanbul, Turkey
- 700 1_
- $a Tufan, Asli $u Division of Geriatrics, Department of Internal Medicine, Marmara University Medical School, Pendik, Istanbul, Turkey
- 700 1_
- $a Karan, Mehmet Akif $u Division of Geriatrics, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Çapa, 34093, Istanbul, Turkey
- 700 1_
- $a Benetos, Athanase $u Pôle « Maladies du Vieillissement, Gérontologie et Soins Palliatifs », and INSERM DCAC u1116, Université de Lorraine, CHRU-Nancy, 54000, Nancy, France
- 700 1_
- $a Cherubini, Antonio $u Geriatria, Accettazione Geriatrica e Centro di Ricerca Per l'invecchiamento, IRCCS INRCA, Ancona, Italy $u Department of Clinical and Molecular Sciences, Universita Politecnica delle Marche, Ancona, Italy
- 700 1_
- $a Drey, Michael $u Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany
- 700 1_
- $a Garfinkel, Doron $u Center for Appropriate Medication Use, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
- 700 1_
- $a Gąsowski, Jerzy $u Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, University Hospital, 2 Jakubowskiego St., Building I, 5th Floor, 30-688, Kraków, Poland
- 700 1_
- $a Renom-Guiteras, Anna $u Department of Geriatric Medicine, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a Kotsani, Marina $u Pôle « Maladies du Vieillissement, Gérontologie et Soins Palliatifs », Université de Lorraine, CHRU-Nancy, Nancy, France
- 700 1_
- $a McCarthy, Lisa $u Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
- 700 1_
- $a Onder, Graziano $u Fondazione Policlinico Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Pazan, Farhad $u Ehemals Institut für Klinische Pharmakologie, Medizinische Fakultät Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
- 700 1_
- $a Piotrowicz, Karolina $u Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, University Hospital, 2 Jakubowskiego St., Building I, 5th Floor, 30-688, Kraków, Poland
- 700 1_
- $a Rochon, Paula $u Women's Age Lab and Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada
- 700 1_
- $a Ruppe, Georg $u European Geriatric Medicine Society (EUGMS), Vienna, Austria
- 700 1_
- $a Thompson, Wade $u Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
- 700 1_
- $a Topinkova, Eva $u Department of Geriatrics and Internal Medicine, First Faculty of Medicine, Charles University, General Faculty Hospital, Prague, Czech Republic $u Faculty of Health and Social Sciences, South Bohemian University, Ceske Budejovice, Czech Republic
- 700 1_
- $a van der Velde, Nathalie $u Internal Medicine, Section of Geriatric Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands $u Amsterdam Public Health, Aging and Later Life, Amsterdam, The Netherlands
- 700 1_
- $a Petrovic, Mirko $u Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Ghent, Ghent, Belgium
- 773 0_
- $w MED00001454 $t Drugs &aging $x 1179-1969 $g Roč. 42, č. 1 (2025), s. 57-67
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39688727 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134546 $b ABA008
- 999 __
- $a ok $b bmc $g 2311660 $s 1247519
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 42 $c 1 $d 57-67 $e 20241217 $i 1179-1969 $m Drugs &aging $n Drugs Aging $x MED00001454
- LZP __
- $a Pubmed-20250415
